Skip to content
ووگلی‌بوز

Structure via PubChem · Public domain (PubChem)

EntityQ7939403· pop 9· linked from 142 articles

ووگلی‌بوز

Sign in to save

Also known as A-71100, AO-128, Basen, Glustat, Voglibose

Voglibose (INN and USAN, trade name Voglib, marketed by Mascot Health Series) is an alpha-glucosidase inhibitor used for lowering postprandial blood glucose levels in people with diabetes mellitus. Voglibose is a research product of Takeda Pharmaceutical Company, Japan's largest pharmaceutical company. Voglibose was discovered in 1981, and was first launched in Japan in 1994, under the trade name BASEN, to improve postprandial hyperglycemia in diabetes mellitus.

Chemical data

Formula
C10H21NO7
Molecular weight
267.28 g/mol
IUPAC name
(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
SMILES
C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO
InChIKey
FZNCGRZWXLXZSZ-CIQUZCHMSA-N
XLogP
-4.1
Polar surface area
154 Ų
H-bond donors
8
H-bond acceptors
8
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
1994
Admin. routes
oral
Indications
diabetes mellitus, type 2 diabetes mellitus

via ChEMBL · EBI

Research

426 papers

via PubMed

Wikidata facts

Mass
267.131802
Has use
medication
Show 6 more facts
Commons category
Voglibose
defined daily dose
0.6
chemical formula
C₁₀H₂₁NO₇
canonical SMILES
C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO
isomeric SMILES
C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO
medical condition treated
diabetes
Sources (5)

via Wikidata · CC0

Available in 8 languages

via Wikidata sitelinks · CC0